- https://www.novartis.com/stories/can-data-from-heart-disease-trial-lead-potential-cancer-treatment
Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.
- https://www.novartis.com/stories/cancer-research-drives-breast-cancer-treatment-forward
Novartis team perseveres to develop more personalized approach to breast cancer therapy.
- https://www.novartis.com/stories/discovery-gives-cystic-fibrosis-researchers-new-direction
Novartis-Harvard team identifies a new type of cell that is key to the disease.
- https://www.novartis.com/stories/guidance-system-lights-path-drug-discovery
Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.
- https://www.novartis.com/stories/need-new-heart-disease-medicines-drives-wave-potential-therapies
Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
- https://www.novartis.com/stories/researchers-boost-understanding-t-cell-therapy-blood-cancer
Novartis investigators find genetic explanations for why some young patients relapse.
- https://www.novartis.com/stories/novartis-and-uc-berkeley-take-undruggable-proteins-new-collaboration
Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
- https://www.novartis.com/stories/striving-vanquish-leukemia
Combination of two compounds shows promise in the lab
- https://www.novartis.com/stories/sourcing-innovation-strategically
Phil Gotwals talks about his vision for the future of business development for research.
- https://www.novartis.com/stories/take-visual-tour-medicines-target-rna
A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 38
- › Next page